Literature DB >> 457286

Mechanism of lipopolysaccharide-induced tumor necrosis: requirement for lipopolysaccharide-sensitive lymphoreticular cells.

D N Männel, D L Rosenstreich, S E Mergenhagen.   

Abstract

Lipopolysaccharide (LPS) induces rapid necrosis of intradermal fibrosarcomas in mice. The mechanism(s) by which LPS produces tumor necrosis has been investigated using histocompatible LPS-sensitive (C3H/HeN) and LPS-resistant (C3H/HeJ) mouse strains. C3H/HeN- or C3H/HeJ-derived fibrosarcomas were necrotized by LPS when they were grafted onto C3H/HeN mice but were not affected when growing on C3H/HeJ mice, indicating that LPS does not act directly on the tumor itself. In contrast, lethally X-irradiated C3H/HeJ mice exhibit necrosis of their tumors when reconstituted with C3H/HeN bone marrow cells, whereas C3H/HeN mice no longer exert LPS-induced tumor necrosis after the adoptive transfer of C3H/HeJ bone marrow cells. These findings clearly indicate that LPS produces necrosis of tumors by activating host lymphoreticular cells.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 457286      PMCID: PMC414341          DOI: 10.1128/iai.24.2.573-576.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  12 in total

1.  Vascular reactions of normal and malignant tissues in vivo. V. The rôle of hypotension in the action of a bacterial polysaccharide on tumors.

Authors:  G H ALGIRE; F Y LEGALLAIS; B F ANDERSON
Journal:  J Natl Cancer Inst       Date:  1952-06       Impact factor: 13.506

2.  Suppression of murine tumor growth by immune reaction to the Bacillus Calmette-Guérin strain of Mycobacterium bovis.

Authors:  G L Bartlett; B Zbar; H J Rapp
Journal:  J Natl Cancer Inst       Date:  1972-01       Impact factor: 13.506

3.  Immunologic and antineoplastic effects of endotoxin: role of membranes and mediation by cyclic adenosine-3',5'-monophosphate.

Authors:  W Braun
Journal:  J Infect Dis       Date:  1973-07       Impact factor: 5.226

4.  Macrophage activation for tumor cytotoxicity: control of macrophage tumoricidal capacity by the LPS gene.

Authors:  L P Ruco; M S Meltzer; D L Rosenstreich
Journal:  J Immunol       Date:  1978-08       Impact factor: 5.422

5.  Significant contribution of spleen cells in mediating the lethal effects of endotoxin in vivo.

Authors:  L M Glode; S E Mergenhagen; D L Rosenstreich
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

6.  Partial purification of a serum factor that causes necrosis of tumors.

Authors:  S Green; A Dobrjansky; E A Carswell; R L Kassel; L J Old; N Fiore; M K Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1976-02       Impact factor: 11.205

7.  Lymphoid cells in endotoxin-induced production of the amyloid-related serum amyloid A protein.

Authors:  D L Rosenstreich; K P McAdam
Journal:  Infect Immun       Date:  1979-01       Impact factor: 3.441

8.  Bone marrow colony-stimulating factor and tumor resistance-enhancing activity of postendotoxin mouse sera.

Authors:  R C Butler; A M Abdelnoor; A Nowotny
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

9.  Requirement for a radiosensitive lymphoid cell in the generation of lipopolysaccharide-induced rejection of a murine tumor allograft.

Authors:  M J Berendt; G F Mezrow; P H Saluk
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

10.  Similarities of the anti-tumour actions of endotoxin, lipid A and double-stranded RNA.

Authors:  I Parr; E Wheeler; P Alexander
Journal:  Br J Cancer       Date:  1973-05       Impact factor: 7.640

View more
  11 in total

1.  Stabilization of Nrf2 by tBHQ prevents LPS-induced apoptosis in differentiated PC12 cells.

Authors:  Fariba Khodagholi; Solaleh Khoramian Tusi
Journal:  Mol Cell Biochem       Date:  2011-04-02       Impact factor: 3.396

2.  Tumor necrosis factor induces tumor necrosis via tumor necrosis factor receptor type 1-expressing endothelial cells of the tumor vasculature.

Authors:  B Stoelcker; B Ruhland; T Hehlgans; H Bluethmann; T Luther; D N Männel
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

3.  Effect of bacterial lipopolysaccharide on growth of murine bladder cancer, MBT-2.

Authors:  K Lee; J F Ewing; P M Sluss
Journal:  Urol Res       Date:  1989

4.  Role of histamine in the antitumour activity of endotoxin.

Authors:  N Bloksma; P van de Wiel; F Hofhuis; F Kuper; J Willers
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

5.  Muramyl dipeptide analogues as potentiators of the antitumor action of endotoxin.

Authors:  N Bloksma; F M Hofhuis; J M Willers
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

6.  Generation and characterization of a lipopolysaccharide-induced and serum-derived cytotoxic factor for tumor cells.

Authors:  D N Männel; M S Meltzer; S E Mergenhagen
Journal:  Infect Immun       Date:  1980-04       Impact factor: 3.441

7.  Synergistic action of human recombinant tumor necrosis factor with endotoxins or nontoxic poly A:U against solid Meth A tumors in mice.

Authors:  N Bloksma; F M Hofhuis
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

8.  Macrophages from endotoxin-hyporesponsive (Lpsd) C3H/HeJ mice are permissive for vesicular stomatitis virus because of reduced levels of endogenous interferon: possible mechanism for natural resistance to virus infection.

Authors:  S N Vogel; D Fertsch
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

9.  Enhancement of resistance to infections by endotoxin-induced serum factor from Mycobacterium bovis BCG-infected mice.

Authors:  M A Parant; F J Parant; L A Chedid
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

10.  Induction of Suppressor Cells and Increased Tumor Growth following Chronic Psychosocial Stress in Male Mice.

Authors:  Dominic Schmidt; Daniel Peterlik; Stefan O Reber; Anja Lechner; Daniela N Männel
Journal:  PLoS One       Date:  2016-07-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.